Alpha-2 Receptor Agonists Market Size & Share, by Use (Hypertension, ADHD, Pain & Panic Disorder, ICU & Procedural Sedation); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 3265
  • Published Date: Jan 03, 2024
  • Report Format: PDF, PPT

Companies Dominating the Alpha-2 Receptor Agonist Landscape

    • Pfizer Inc.
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
    • Merck & Co., Inc.
    • Viatris Inc. 
    • Amneal Pharmaceuticals LLC.
    •  Unichem Pharmaceuticals USA INC
    • Seqens Group
    • Teva Pharmaceuticals USA, Inc.
    • Ajanta Pharma Ltd.
    • Boehringer Ingelheim International GmbH.
    • Dr. Reddy’s Laboratories

Browse Key Market Insights with Data Illustration:


In The News

  • March 2023- Pfizer and Seagen, a multinational biotechnology business that specializes in antibody-drug conjugates (ADC), announced a formal merger agreement.
  • September 2020- Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, a therapeutically similar generic version of Precedex® (dexmedetomidine hydrochloride) in 0.9% Sodium Chloride Injection that has been approved by the US Food and Drug Administration (USFDA), was introduced by Dr. Reddy's Laboratories Ltd.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 3265
  • Published Date: Jan 03, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising cases of hypertension, growing awareness regarding ADHD, the rising aging population, and growing adoption of pain management solutions are some of the major growth drivers for the alpha-2 receptor agonist market.

The market size of alpha-2 receptor agonist is anticipated to attain a CAGR of 8.7 % over the forecast period, i.e., 2024 – 2036.

The major players in the market are Pfizer Inc., Merck & Co., Inc., Viatris Inc., Amneal Pharmaceuticals LLC., Unichem Pharmaceuticals USA INC, Seqens Group, Teva Pharmaceuticals USA, Inc., Ajanta Pharma Ltd., Boehringer Ingelheim International GmbH., Otsuka Pharmaceutical Co., Ltd., and others.

The Hypertension segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying